Larvol Delta - Phase-2a-clinical-trial-of-complement-C3-inhibitor-AMY101-in-adults-with-periodontal-inflammation

AMY-101 - Amyndas

http://www.ncbi.nlm.nih.gov/pubmed/34618684

Oct 8, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next